Additionally, MAST4 expression levels were integrated into kinase profiling for myelodysplastic syndromes (MDS), demonstrating prognostic value for disease progression risk stratification and therapeutic target responsiveness (18). The gene discussed is MAST4; the disease is myelodysplastic syndrome.